Big Movers: Boston Scientific Corporation (NYSE:BSX), Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), KKR & Co. L.P. (NYSE:KKR), Illumina (NASDAQ:ILMN), John Wiley & Sons (NYSE:JW-A)

Boston Scientific Corporation (NYSE:BSX) belongs to Healthcare sector. Its net profit margin is -3.40% and weekly performance is 0.17%. On last trading day company shares ended up $17.60. Boston Scientific Corporation (NYSE:BSX) distance from 50-day simple moving average (SMA50) is -1.00%. Boston Scientific Corporation (NYSE:BSX) announces that Bronchial Thermoplasty (BT) delivered by the Alair™ System has received support from the American College of Allergy, Asthma and Immunology (ACAAI). BT is an outpatient procedure proven to reduce asthma attacks in adult patients with severe asthma.1 This endorsement demonstrates a growing clinical acceptance among allergists for this novel, procedure-based treatment option for severe asthma.

Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) shares advanced 2.73% in last trading session and ended the day at $12.41. VNDA Gross Margin is 89.90% and its return on assets is 7.30%. Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) quarterly performance is 30.36%. Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) announced it will release results for the second quarter of 2015 on Wednesday, July 29, 2015, after the market closes.

On 10 July, KKR & Co. L.P. (NYSE:KKR) shares advanced 1.58% and was closed at $23.17. KKR EPS growth in last 5 year was -22.50%. KKR & Co. L.P. (NYSE:KKR) year to date (YTD) performance is 3.33%. KKR & Co. L.P. (NYSE:KKR) announced that it plans to release its financial results for the second quarter 2015 on Thursday, July 23, 2015, before the opening of trading on the New York Stock Exchange.

Illumina Inc. (NASDAQ:ILMN) ended the last trading day at $219.45. Company weekly volatility is calculated as 2.11% and price to cash ratio as 23.14. Illumina Inc. (NASDAQ:ILMN) showed a weekly performance of -0.28%. On July 7, Neogen Corporation (NASDAQ: NEOG) announced today that it has signed an agreement to expand its relationship with Illumina Inc. (NASDAQ:ILMN). Under the agreement, Illumina will market and sell arrays with Neogen’s custom SNP content, built on Illumina Infinium® BeadArray technology, to the global agrigenomics community.

John Wiley & Sons Inc. (NYSE:JW-A) belongs to Services sector. Its net profit margin is 9.70% and weekly performance is -0.65%. On last trading day company shares ended up $54.69. John Wiley & Sons Inc. (NYSE:JW-A) distance from 50-day simple moving average (SMA50) is -3.74%. John Wiley & Sons, Inc. (NYSE: JW-A), announced a new partnership with the University of Delaware that will support the extension of the University’s graduate education to new student markets. The partnership will help grow the current online Master of Education in Teacher Leadership program, and bring the current Master of Public Administration, Master of Science in Electrical and Computer Engineering, and Master of Science in Cybersecurity degrees fully online The programs will enable online students to receive the same excellent educational resources, faculty teaching, and learning outcomes as their on-campus counterparts.

Leave a Reply

Your email address will not be published. Required fields are marked *